Charlotte Jones-Burton
Director/Board Member bij BLUEBIRD BIO, INC.
Vermogen: 23 759 $ op 31-03-2024
Profiel
Charlotte Jones-Burton is the founder of Women of Color in Pharma.
She is currently an Independent Director at bluebird bio, Inc. .
She previously worked as the VP, Global Head-Clinical Development & Nephrology at Otsuka Pharmaceutical Development & Commercialization, Inc. and as the VP-Global Clinical Development & Head-Nephrology at Otsuka Pharmaceuticals (U.K.) Ltd.
In 2022, she held the position of Senior VP-Product Development & Strategy at Chinook Therapeutics, Inc. Dr. Jones-Burton completed her undergraduate studies at Washington University in St. Louis.
She also obtained graduate and doctorate degrees from the University of Maryland School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0.01% | 16-06-2023 | 18 562 ( 0.01% ) | 23 759 $ | 31-03-2024 |
Actieve functies van Charlotte Jones-Burton
| Bedrijven | Functie | Begin |
|---|---|---|
| BLUEBIRD BIO, INC. | Director/Board Member | 07-03-2022 |
| Women of Color in Pharma | Founder | - |
Eerdere bekende functies van Charlotte Jones-Burton
| Bedrijven | Functie | Einde |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 02-10-2023 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The private company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Corporate Officer/Principal | - |
Otsuka Pharmaceuticals (U.K.) Ltd.
 Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The private company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Corporate Officer/Principal | - |
Opleiding van Charlotte Jones-Burton
| Washington University in St. Louis | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The private company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
Otsuka Pharmaceuticals (U.K.) Ltd.
Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The private company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
| Women of Color in Pharma |
